• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强脉冲光联合低强度蓝光和红光治疗睑缘炎

Intense Pulsed Light Combined with Low Level Blue and Red Light Therapy for -Associated Blepharitis.

作者信息

Farrant Sarah, Giannaccare Giuseppe, Lim Chris Hong Long, Coco Giulia

机构信息

Earlam and Christopher Optometrists Ltd, Taunton, UK.

Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, Italy.

出版信息

Clin Ophthalmol. 2025 Aug 7;19:2575-2585. doi: 10.2147/OPTH.S521989. eCollection 2025.

DOI:10.2147/OPTH.S521989
PMID:40792188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12338316/
Abstract

PURPOSE

-associated blepharitis is a chronic disease of the lid accounting for over 60% of all blepharitis. Although several therapies have been employed to address mites' infestation, there is no universal consensus about the most effective strategy. Purpose of this study was to evaluate the efficacy of combined intense pulsed light (IPL) and low-level light therapy (LLLT) in the treatment of -associated blepharitis and associated ocular surface disease (OSD).

PATIENTS AND METHODS

Medical records of patients with -associated blepharitis resistant to first-line therapy who underwent IPL and LLLT (12 minutes of blue light followed by 12 minutes of red light) were retrospectively examined. The following data collected before treatment (T0) and at last follow-up (T1) were reviewed: collarettes (0-4 grade); saponification (presence/absence); lid margin telangiectasia (0-3 grade); conjunctival hyperemia (0-4 grade); corneal fluorescein staining (CFS) (0-5 grade); noninvasive tear break-up time (NITBUT), tear meniscus height (TMH), inter-blink interval (IBI), meibomian gland dropout (0-3 grade) and symptoms (5-item Dry Eye Questionnaire [DEQ-5]). Treatment-related adverse effects (TrAEs) were recorded.

RESULTS

Data from 34 eyes of 17 patients (3 males, 14 females; mean age 64.6±10.0 years) were included. A mean of 7.6 ± 3.6 treatment sessions of IPL and LLLT was performed. Mean score of collarettes decreases significantly from 1.44 ± 0.83 at T0 to 1.00 ± 0.97 at T1 (p = 0.007). The rate of eyes with saponification decreases significantly (from 41.18% to 11.76%; p = 0.002). Conjunctival hyperemia significantly decreased from 2.00 ± 0.78 to 1.47 ± 0.61 (p = 0.005). Mean CFS score decreased significantly from 0.56 ± 1.16 to 0.24 ± 0.96 (p = 0.031). Symptoms' mean score improved significantly after treatment (from 12.00 ± 5.34 to 7.76 ± 4.92; p = 0.003). No patient reported TrAEs.

CONCLUSION

Combined light therapy with IPL and LLLT employing blue and red lights is an effective treatment strategy for patients with recalcitrant -associated blepharitis to reduce mites count and improve main ocular surface parameters along with patients' symptoms.

摘要

目的

睑缘炎相关睑缘炎是一种眼睑慢性疾病,占所有睑缘炎的60%以上。尽管已采用多种疗法来应对螨虫感染,但对于最有效的策略尚无普遍共识。本研究的目的是评估强脉冲光(IPL)和低强度光疗法(LLLT)联合治疗睑缘炎相关睑缘炎及相关眼表疾病(OSD)的疗效。

患者和方法

回顾性检查了接受IPL和LLLT(12分钟蓝光后接12分钟红光)治疗的对一线治疗耐药的睑缘炎相关睑缘炎患者的病历。回顾了治疗前(T0)和最后一次随访(T1)收集的以下数据:鳞屑(0 - 4级);皂化(存在/不存在);睑缘毛细血管扩张(0 - 3级);结膜充血(0 - 4级);角膜荧光素染色(CFS)(0 - 5级);无创泪膜破裂时间(NITBUT)、泪河高度(TMH)、眨眼间隔(IBI)、睑板腺缺失(0 - 3级)和症状(5项干眼问卷[DEQ - 5])。记录与治疗相关的不良反应(TrAEs)。

结果

纳入了17例患者(3例男性,14例女性;平均年龄64.6±10.0岁)的34只眼的数据。平均进行了7.6±3.6次IPL和LLLT治疗。鳞屑的平均评分从T0时的1.44±0.83显著降至T1时的1.00±0.97(p = 0.007)。有皂化的眼的比例显著降低(从41.18%降至11.76%;p = 0.002)。结膜充血从2.00±0.78显著降至1.47±0.61(p = 0.005)。平均CFS评分从0.56±1.16显著降至0.24±0.96(p = 0.031)。治疗后症状的平均评分显著改善(从12.00±5.34降至7.76±4.92;p = 0.003)。没有患者报告TrAEs。

结论

采用蓝光和红光的IPL和LLLT联合光疗是治疗顽固性睑缘炎相关睑缘炎患者以减少螨虫数量、改善主要眼表参数及患者症状的有效治疗策略。

相似文献

1
Intense Pulsed Light Combined with Low Level Blue and Red Light Therapy for -Associated Blepharitis.强脉冲光联合低强度蓝光和红光治疗睑缘炎
Clin Ophthalmol. 2025 Aug 7;19:2575-2585. doi: 10.2147/OPTH.S521989. eCollection 2025.
2
Interventions for chronic blepharitis.慢性睑缘炎的干预措施。
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD005556. doi: 10.1002/14651858.CD005556.pub2.
3
Meibomian gland structure and function in patients with Demodex blepharitis.蠕形螨睑缘炎患者睑板腺的结构与功能
J Cataract Refract Surg. 2025 May 1;51(5):359-365. doi: 10.1097/j.jcrs.0000000000001619.
4
Intense pulsed light therapy to improve signs and symptoms of contact lens discomfort.强脉冲光疗法改善隐形眼镜不适的体征和症状。
Cont Lens Anterior Eye. 2025 Aug 11:102486. doi: 10.1016/j.clae.2025.102486.
5
Lubricating drops for contact lens discomfort in adults.成人接触镜不适润滑滴眼剂。
Cochrane Database Syst Rev. 2024 Sep 5;9(9):CD015751. doi: 10.1002/14651858.CD015751.pub2.
6
Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study.为期 6 周的 0.25%洛替拉纳滴眼液治疗蠕形螨性睑缘炎的长期疗效:一项非干预性扩展研究。
Cornea. 2024 Nov 1;43(11):1368-1374. doi: 10.1097/ICO.0000000000003484. Epub 2024 Feb 9.
7
Prevalence of in a university-based population.某大学人群中……的患病率。(原文“Prevalence of in a university-based population.”中“of”后面缺少具体内容)
Clin Exp Optom. 2025 Jun 26:1-8. doi: 10.1080/08164622.2025.2517754.
8
Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% in Demodex Blepharitis: A Systematic Review.0.25%氯虫苯甲酰胺滴眼液治疗睑缘蠕形螨睑缘炎的疗效和安全性:一项系统评价。
HCA Healthc J Med. 2025 Jun 1;6(3):213-223. doi: 10.36518/2689-0216.1985. eCollection 2025.
9
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.用于保护黄斑健康的蓝光滤过型人工晶状体
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
BlephEx-treatment for blepharitis: a prospective randomized placebo-controlled trial.BlephEx 治疗睑缘炎:一项前瞻性随机安慰剂对照试验。
BMC Ophthalmol. 2024 Nov 18;24(1):503. doi: 10.1186/s12886-024-03765-3.
2
Photobiomodulation use in ophthalmology - an overview of translational research from bench to bedside.光生物调节在眼科中的应用——从实验台到临床的转化研究综述
Front Ophthalmol (Lausanne). 2024 Aug 15;4:1388602. doi: 10.3389/fopht.2024.1388602. eCollection 2024.
3
The impact of Demodex blepharitis on patient symptoms and daily life.
睑缘蠕形螨病对患者症状和日常生活的影响。
Optom Vis Sci. 2024 Mar 1;101(3):151-156. doi: 10.1097/OPX.0000000000002111. Epub 2024 Feb 7.
4
Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).Lotilaner 眼科溶液 0.25%用于治疗蠕形螨睑缘炎:随机、对照、多中心、3 期临床试验(Saturn-2)。
Ophthalmology. 2023 Oct;130(10):1015-1023. doi: 10.1016/j.ophtha.2023.05.030. Epub 2023 Jun 5.
5
Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies.睑缘蠕形螨病:疾病的全面综述、当前管理及新兴疗法。
Eye Contact Lens. 2023 Aug 1;49(8):311-318. doi: 10.1097/ICL.0000000000001003. Epub 2023 Jun 2.
6
Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH).蠕形螨睑缘炎的临床诊断与管理:蠕形螨治疗与眼睑健康专家小组(DEPTH)
Eye (Lond). 2023 Oct;37(15):3249-3255. doi: 10.1038/s41433-023-02500-4. Epub 2023 Mar 24.
7
Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study.低水平激光疗法与强脉冲光治疗睑板腺功能障碍的比较:一项前瞻性随机对照研究的初步结果。
Cornea. 2023 Feb 1;42(2):141-144. doi: 10.1097/ICO.0000000000002997. Epub 2022 Feb 2.
8
Psychosocial Impact of Blepharitis.睑缘炎的社会心理影响
Clin Ophthalmol. 2022 Sep 2;16:2979-2987. doi: 10.2147/OPTH.S374530. eCollection 2022.
9
Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1).Lotilaner 眼科溶液,0.25%,用于治疗蠕形螨睑缘炎:一项前瞻性、随机、对照、双盲、关键试验(Saturn-1)的结果。
Cornea. 2023 Apr 1;42(4):435-443. doi: 10.1097/ICO.0000000000003097. Epub 2022 Aug 10.
10
The Prevalence of Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign.通过睑缘环(一种具有诊断意义的体征)确定美国眼科护理门诊患者睑缘炎的患病率。
Clin Ophthalmol. 2022 Apr 15;16:1153-1164. doi: 10.2147/OPTH.S354692. eCollection 2022.